Literature DB >> 28450277

Absence of the NOD2 protein renders epithelia more susceptible to barrier dysfunction due to mitochondrial dysfunction.

Alpana Saxena1, Fernando Lopes1, Karen K H Poon1, Derek M McKay2.   

Abstract

Irregular mitochondria structure and reduced ATP in some patients with IBD suggest that metabolic stress contributes to disease. Loss-of-function mutation in the nucleotide-binding oligomerization domain (NOD)-2 gene is a major susceptibility trait for IBD. Hence, we assessed if loss of NOD2 further impairs the epithelial barrier function instigated by disruption of mitochondrial ATP synthesis via the hydrogen ionophore dinitrophenol (DNP). NOD2 protein (virtually undetectable in epithelia under basal conditions) was increased in T84 (human colon cell line) cells treated with noninvasive Escherichia coli + DNP (16 h). Increased intracellular bacteria in wild-type (WT) and NOD2 knockdown (KD) cells and colonoids from NOD2-/- mice were mediated by reactive oxygen species (ROS) and the MAPK ERK1/2 pathways as determined by cotreatment with the antioxidant mitoTEMPO and the ERK inhibitor U0126: ROS was upstream of ERK1/2 activation. Despite increased E. coli in DNP-treated NOD2 KD compared with WT cells, there were no differences in the internalization of fluorescent inert beads or dead E. coli particles. This suggests that lack of killing in the NOD2 KD cells was responsible for the increased numbers of viable intracellular bacteria; a conclusion supported by evidence of reduced autophagy in NOD2 KD T84 epithelia. Thus, in a two-hit hypothesis, decreased barrier function due to dysfunctional mitochondrial is amplified by lack of NOD2 in transporting enterocytes: subsequently, greater numbers of bacteria entering the mucosa would be a significant inflammatory threat especially since individuals with NOD2 mutations have compromised macrophage and Paneth cell responses to bacteria.NEW & NOTEWORTHY Increased internalization of bacteria by epithelia with dysfunctional mitochondria (reduced ATP) is potentiated if the cells lack nucleotide-binding oligomerization domain 2 (NOD2), mutations in which are inflammatory bowel disease-susceptibility traits. Uptake of bacteria was dependent on reactive oxygen species and MAP-kinase activity, and the increased viable intracellular bacteria in NOD2-/- cells likely reflect a reduced ability to recognize and kill bacteria. Thus a significant barrier defect occurs with NOD2 deficiency in conjunction with metabolic stress that could contribute to inflammation.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  NOD2; barrier; commensal bacteria; epithelium; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28450277     DOI: 10.1152/ajpgi.00070.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  16 in total

1.  ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.

Authors:  Fernando Lopes; Åsa V Keita; Alpana Saxena; Jose Luis Reyes; Nicole L Mancini; Ala Al Rajabi; Arthur Wang; Cristiane H Baggio; Michael Dicay; Rob van Dalen; Younghee Ahn; Matheus B H Carneiro; Nathan C Peters; Jong M Rho; Wallace K MacNaughton; Stephen E Girardin; Humberto Jijon; Dana J Philpott; Johan D Söderholm; Derek M McKay
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

Review 2.  Mitochondria: at the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease.

Authors:  Mahyar Aghapour; Alexander H V Remels; Simon D Pouwels; Dunja Bruder; Pieter S Hiemstra; Suzanne M Cloonan; Irene H Heijink
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

3.  Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease.

Authors:  Emmanuelle Ruiz; Harrison M Penrose; Sandra Heller; Hani Nakhoul; Melody Baddoo; Erik F Flemington; Emad Kandil; Suzana D Savkovic
Journal:  Gut Microbes       Date:  2019-05-07

Review 4.  Patient-derived organoids for therapy personalization in inflammatory bowel diseases.

Authors:  Marianna Lucafò; Antonella Muzzo; Martina Marcuzzi; Lorenzo Giorio; Giuliana Decorti; Gabriele Stocco
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

5.  Reduced intestinal epithelial mitochondrial function enhances in vitro interleukin-8 production in response to commensal Escherichia coli.

Authors:  Alpana Saxena; Fernando Lopes; Derek M McKay
Journal:  Inflamm Res       Date:  2018-07-20       Impact factor: 4.575

Review 6.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

Review 7.  Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury.

Authors:  Eva Rath; Dirk Haller
Journal:  Mucosal Immunol       Date:  2022-05-09       Impact factor: 8.701

Review 8.  Organoids Provide an Important Window on Inflammation in Cancer.

Authors:  Kristi Baker
Journal:  Cancers (Basel)       Date:  2018-05-21       Impact factor: 6.639

9.  Telomere dysfunction instigates inflammation in inflammatory bowel disease.

Authors:  Deepavali Chakravarti; Rumi Lee; Asha S Multani; Andrea Santoni; Zachery Keith; Wen-Hao Hsu; Kyle Chang; Laura Reyes; Asif Rashid; Chang-Jiun Wu; Jun Li; Jiexin Zhang; Hong Seok Shim; Krishna Chandra; Pingna Deng; Denise J Spring; Ole Haagen Nielsen; Lene Buhl Riis; Kavya Kelagere Mayigegowda; Sarah E Blutt; Jianhua Zhang; Mamoun Younes; Andrew DuPont; Selvi Thirumurthi; Eduardo Vilar; Mary K Estes; Simona Colla; Noah F Shroyer; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

Review 10.  NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis.

Authors:  Audrey Ferrand; Ziad Al Nabhani; Núria Solà Tapias; Emmanuel Mas; Jean-Pierre Hugot; Frédérick Barreau
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.